GlassScriptPhysician profile
Susana Ayad Carter
NPI 1184365116
$570.71
in general payments reported to CMS, 2019-2025
16 companies · $551 in 2025
The $551 reported for 2025 was more than what 76% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $19.78 · 2025: $551.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $571.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $570.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Beta Bionics, INC. | $119.09 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Medtronic, INC. | $66.62 | 2025 | Minimed 780g |
| Merck Sharp & Dohme LLC | $56.04 | 2025 | Zerbaxa |
| Ascendis Pharma Endocrinology INC | $50.31 | 2025 | Yorvipath |
| Tandem Diabetes Care, INC. | $40.40 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Paratek Pharmaceuticals, INC. | $37.46 | 2025 | Nuzyra |
| Mallinckrodt Hospital Products INC. | $27.02 | 2025 | Acthar |
| Novo Nordisk INC | $25.72 | 2025 | Ozempic |
| Dexcom, INC. | $23.89 | 2025 | Dexcom G6 Transmitter |
| Baxter Healthcare | $23.79 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Ironshore Pharmaceuticals INC. | $19.78 | 2024 | |
| Corcept Therapeutics | $18.12 | 2025 | Korlym |
| Merz Pharmaceuticals, LLC | $16.84 | 2025 | Xeomin, Inbrija |
| Ucb, INC. | $16.76 | 2025 | Bimzelx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.96 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $13.91 | 2025 | Zepbound, Mounjaro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susana Carter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.